This article is based on a poster originally authored by Malika Bsibsi, A. Popalzij, Matteo Zanella, Lieke Geerts, Mark Musters, Inês Ferreira, Stefan Kostense, David F. Fischer and Marijn Vlaming, ...
Pluristyx's iPSC platform provides therapeutic developers with a streamlined path from research to clinical application, offering high-quality, regulatory-compliant starting materials and advanced ...
In the dynamic field of neuroscience, the introduction and utilization of human induced pluripotent stem cells (hiPSCs) have ...
MILPITAS, Calif., June 24, 2025 (GLOBE NEWSWIRE) -- Applied StemCell, a leading provider of advanced stem cell and gene editing technologies since 2008, today announced the release of hiEX™ Research ...
Experts in the emerging field of iPSC banking urge action on several fronts to ensure that iPSCs realize their full potential for improved drug screening, disease modeling, and medical treatments.
Allo-Evasion™ 5.0-engineered iPSC beta islets are designed to overcome immune rejection and provide durable glucose control without chronic ...
TipRanks on MSN
Century Therapeutics Launches Type 1 Diabetes Program
Century Therapeutics ( ($IPSC) ) just unveiled an announcement. On November 13, 2025, Century Therapeutics announced the launch of its first ...
The "Induced Pluripotent Stem Cell (iPSC) Industry Report - Market Size, Trends, & Forecasts, 2025" report has been added to ResearchAndMarkets.com's offering. Since the discovery of induced ...
Accelerated Biosciences and Stemmatters are thrilled to announce their strategic partnership aimed at co-developing and co-marketing human induced pluripotent stem cells (“iPSC”) derived from human ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback